Published in Health Risk Factor Week, June 9th, 2009
Under terms of this new agreement, Grifols will sell, deploy and support the INTERCEPT Blood System in Italy. In 2007, the companies entered a similar distribution agreement for Spain and Portugal, and in 2008 the territory was expanded to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.